Articles From: Investors pulled $2.3 bln from high yield bond funds this week to iPass to Report Third Quarter 2014 Financial Results on November 6


2014/10/2
Investors pulled a net $2.3 billion from high yield bond mutual funds and exchange traded funds during the week ended Wednesday, according to Lipper data released Thursday.
Sign-up for Investors pulled $2.3 bln from high yield bond funds this week investment picks
2014/10/20
By Maureen Farrell A consortium of investors from Hong Kong and Abu Dhabi is launching a bid to buy Reebok from Adidas AG in a move that, if successful, would unwind an eight-year-old marriage of sneaker makers that has shown disappointing results.
Sign-up for Investors seek to buy Adidas's Reebok unit investment picks
2014/11/13
By Michael BrushThe company, whose stock begins trading Friday, stands apart from its competitors Now boarding at Gate 21: one of the first airline initial public offerings in years, Virgin America.
Sign-up for Investors should consider flying Virgin America investment picks
2014/9/26
By Victor Reklaitis, MarketWatch NEW YORK (MarketWatch) -- In Roman mythology Janus is the god of transitions.
Sign-up for Investors should think twice about following Bill Gross to Janus investment picks
2014/11/3
Investors Title Company today announced its results for the third quarter ended September 30, 2014.
Sign-up for Investors Title Company Announces Third Quarter 2014 Results investment picks
J. Allen Fine, Chairman of the Board of Investors Title Company (NASDAQ: ITIC), announced today that the Company's Board of Directors has declared a cash dividend of $.08 per share to shareholders of record December 1, 2014, payable December 15, 2014.
Sign-up for Investors Title Company Declares Quarterly Dividend investment picks
2014/11/5
Invetech to supply automated production systems for commercialization of patient-specific immunotherapies based on Argos' proprietary Arcelis® technology platform.
Sign-up for Invetech And Argos Therapeutics Announce Agreement To Support Global Production Of Fully Personalized Immunotherapies investment picks
Autoliv Inc. (STO:ALIVSDB)(NYSE:ALV) plans to publish its Financial Report for the third quarter of 2014 on Thursday October 23, at 12:00, Central European Time (11:00 UK Time, 6:00 am ET). The report will be available at www.autoliv.com under Quarterly Reports.
Sign-up for Invitation to Autoliv’s Q3, 2014, Teleconference investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?docid=0979099001&sourceType=1 http://www.ccnmatthews.com/logos1/tcs.jpg MONTREAL, QUEBEC --
Sign-up for Invitation to TECSYS' Q2 FY2015 Results Conference Call on November 25, 2014 investment picks
2014/9/19
Sign-up for Invitation to the media - Shareholders' Annual Meeting investment picks
2014/9/19
LAVAL, QC , Sept.
Sign-up for Invitation to the media - Shareholders' Annual Meeting investment picks
2014/11/17
By Jason Ng KUALA LUMPUR--IOI Corp.
Sign-up for IOI First-Quarter Net Profit Falls 41% investment picks
iomart (AIM: IOM), one of Europe’s leading cloud companies, has created a bespoke, private cloud solution to support a new social sharing site that is being backed by the original publishers of Angry Birds.
Sign-up for iomart Private Cloud Supports Social Sharing Site Backed by Angry Birds Publishers investment picks
2014/11/3
HOUSTON , Nov.
Sign-up for ION announces third quarter 2014 earnings and conference call schedule investment picks
2014/11/13
HOUSTON , Nov.
Sign-up for ION Geophysical Appoints New Chief Financial Officer investment picks
2014/11/5
Revenues increased 33% to $107 million HOUSTON , Nov.
Sign-up for ION reports third quarter 2014 results investment picks
2014/9/26
HOUSTON , Sept.
Sign-up for ION to present at the 2014 Johnson Rice Energy Conference investment picks
2014/12/9
TAMA, Iowa, Dec.
Sign-up for Iowa Premium Beef Selects OneNeck(R) IT Solutions to Provide New Communications Platform investment picks
LONDON--Modern Biosciences PLC, a late-stage drug discovery company 61.1% owned by U.K. technology investor IP Group PLC (IPO.LN), has formed a research and development and licensing agreement with Janssen Biotech Inc. The aim of the collaboration, to be facilitated by Johnson & Johnson's (JNJ) Innovation Centre in London, is to develop rheumatoid arthritis treatments based on Modern Biosciences' novel bone-protective compounds, IP Group said Thursday.
Sign-up for IP Group's Modern Biosciences Forms Arthritis Partnership With Janssen investment picks
http://media.marketwire.com/attachments/201205/45305_iPasslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148719&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Appoints Michael Tedesco to Board of Directors investment picks
http://media.marketwire.com/attachments/201205/45279_iPasslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1154804&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Makes Significant Improvements to iPass App for Android investment picks
http://media.marketwire.com/attachments/201404/73822_ipass.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1157068&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass Reports Sequential OM Revenue Growth in the Third Quarter 2014 investment picks
http://media.marketwire.com/attachments/201311/200249_iPass_logo_color.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1161687&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass to Present at the LD Micro Conference investment picks
http://media.marketwire.com/attachments/201205/45279_iPasslogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1153492&ProfileId=051205&sourceType=1 REDWOOD SHORES, CA --
Sign-up for iPass to Report Third Quarter 2014 Financial Results on November 6 investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Investors pulled $2.3 bln from high yield bond funds this week to iPass to Report Third Quarter 2014 Financial Results on November 6
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent